Pasithea Therapeutics Corp.
KTTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001841330
No open-market purchases or sales by Pasithea Therapeutics Corp. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $8.66M in total; no superinvestor holds it.
Other share classesKTTAW
13F holders, Q3 2023
Institutional positions in Pasithea Therapeutics Corp. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- 0 vs. Q2 2023
- Shares held
- 255.4K
- −122.7K (−32.4%) vs. Q2 2023
- Total value
- $121.9K
- −$62.4K (−33.9%) vs. Q2 2023
- New holders
- 4
- 3 more added
- Sold out
- 4
- 3 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KTTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 25 | $8.66M |
| Q1 2026 | 21 | $9.52M |
| Q4 2025 | 26 | $16.7M |
| Q3 2025 | 19 | $441.4K |
| Q2 2025 | 11 | $216.6K |
| Q1 2025 | 8 | $99.1K |
| Q4 2024 | 7 | $243.3K |
| Q3 2024 | 6 | $48.9K |
| Q2 2024 | 7 | $151.6K |
| Q1 2024 | 6 | $218.1K |
| Q4 2023 | 8 | $94.7K |
| Q3 2023 | 12 | $121.9K |
| Q2 2023 | 12 | $184.3K |
| Q1 2023 | 12 | $147.7K |
| Q4 2022 | 11 | $405.6K |
| Q3 2022 | 9 | $1.03M |
| Q2 2022 | 10 | $662.1K |
| Q1 2022 | 8 | $985.0K |
| Q4 2021 | 7 | $1.09M |
| Q3 2021 | 4 | $1.26M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Pasithea Therapeutics Corp.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 125,123 | $60.1K | 0.00% | +26,875+27.4% | Added |
| Susquehanna International Group, LLP | 38,568 | $18.5K | 0.00% | +38,568 | New |
| Renaissance Technologies LLC | 30,864 | $15.0K | 0.00% | −3,863−11.1% | Reduced |
| Virtu Financial LLC | 15,469 | $7.00K | 0.00% | −1,460−8.6% | Reduced |
| Tower Research Capital LLC (TRC) | 12,490 | $6.00K | 0.00% | +10.0% | Added |
| XTX Topco Ltd | 10,726 | $5.14K | 0.00% | +10,726 | New |
| Naples Global Advisors, LLC | 10,620 | $5.09K | 0.00% | +10,620 | New |
| Royal Bank of Canada | 5,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Mark Sheptoff Financial Planning, LLC | 3,323 | $1.59K | 0.00% | +3,323 | New |
| JPMorgan Chase & Co | 3,000 | $1.44K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 151 | $72 | 0.00% | +32+26.9% | Added |
| UBS Group AG | 83 | $40 | 0.00% | −6,841−98.8% | Reduced |
| Vanguard Group Inc | 0 | $0 | 0.00% | −121,007−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −41,133−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −23,647−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −14,862−100.0% | Sold out |